Bright Minds Biosciences Announces Stock Option Grants
Vancouver, British Columbia, May 4, 2021 – Bright Minds Biosciences Inc. (CSE:DRUG) (“Bright Minds” or the “Company”) announces that it has granted an aggregate of 240,000 stock options (the “Options”) to consultants of the Company to purchase 240,000 common shares (the “Shares”)in the capital of the Company pursuant to the Company’s share option plan. The…
